Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Penile Neoplasms

• Sacituzumab Govitecan With or Without Atezolizumab Immunotherapy in Rare Genitourinary Tumors (SMART) Such as Small Cell, Adenocarcinoma, and Squamous Cell Bladder/Urinary Tract Cancer, Renal Medullary Carcinoma and Penile Cancer
• Enfortumab Vedotin for the Treatment of Patients With Metastatic or Unresectable Squamous Cell Carcinoma of the Penis
• E7 TCR-T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers
• Safety, Tolerability and Pharmacokinetics Investigation of Stimotimagene Copolymerplasmid
• Study of the Combination Dostarlimab With Niraparib In Patients With Penile Carcinoma
• Image Guided Penile Cancer Surgery
• Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer
• TIP (Paclitaxel + Ifosfamide + Cisplatin) Combined With Nimotuzumab & Triprilimab as Neoadjuvant Treatment in Locally Advanced Penile Cancer
• Efficacy of Immunotherapy Plus a Drug in Patients With Progressive Advanced Mucosal Cancer of Different Locations
• Efficacy of INCMGA00012 in Penile Squamous Cell Carcinoma (ORPHEUS)
• Pembrolizumab Combined With Cisplatin-based Chemotherapy as First-line Systemic Therapy in Advanced Penile Cancer
• Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
• Maintenance Avelumab Immunotherapy in Patients With Locally Advanced or Metastatic Squamous Cell Penile Carcinoma
• PEnile Cancer Radio- and Immunotherapy CLinical Exploration Study
• M7824 in Subjects With HPV Associated Malignancies
• HPV Anti-CD40 RNA Vaccine
• A Study of Avelumab in Penile Cancer Who Are Unfit for or Have Progressed After Platinum-Based Chemotherapy
• Nivolumab Combined With Ipilimumab for Patients With Advanced Rare Genitourinary Tumors
• A Trial of Cabazitaxel Chemotherapy in Relapsed Locally Advanced &/or Metastatic Carcinoma of the Penis
• Secured Access to Nivolumab for Adult Patients With Selected Rare Cancer Types
• E7 TCR T Cells for Human Papillomavirus-Associated Cancers
• Evaluation of Lymphadenectomy and Chemotherapy TIP on Inguinal Lymph Nodes in Squamous Cell Carcinoma of the Penis
• Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors
• T Cell Receptor Immunotherapy Targeting HPV-16 E6 for HPV-Associated Cancers
• A Phase II Trial of Vinflunine Chemotherapy in Locally-advanced and Metastatic Carcinoma of the Penis (VinCaP)
• Efficacy and Safety of Cetuximab in Metastatic Penile Carcinoma (PENILANE)
• Dacomitinib (PF-00299804) in Advanced/Metastatic Squamous Cell Carcinoma of the Penis
• Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Human Papillomavirus-Associated Cancers
• Cancer in Patients With Gabapentin (GPRD)
• Pharmacological Penile Rehabilitation in the Preservation of Erectile Function Following Bilateral Nerve-Sparing Radical Prostatectomy
• Neoadjuvant Chemotherapy for Patients With Squamous Cell Carcinoma of the Penis
• Irinotecan and Cisplatin in Treating Patients With Locally Advanced or Metastatic Penile Cancer
• S0224, Docetaxel in Treating Patients With Locally Advanced or Metastatic Penile Cancer (TERMINATED)
• Isotretinoin Plus Interferon in Treating Patients With Recurrent Cancer